The U.S. biomaterials market size was estimated at USD 59.3 billion in 2023 and is expected to grow at a CAGR of 14.8% from 2024 to 2030. The surge in the need for biomaterials is tied to an increase in accidental injuries and a higher incidence of chronic diseases. Moreover, the interest in innovative biomaterials ... Read More »
April 2024The U.S. biotechnology market size was estimated at USD 552.40 billion in 2023 and is expected to grow at a CAGR of 12.4% from 2024 to 2030. Government support plays a major role in propelling market growth, focusing on modernizing regulatory frameworks, enhancing approval processes and ... Read More »
April 2024The U.S. genome editing market size was estimated at USD 3.49 billion in 2023 and is expected to grow at a CAGR of 16.5% from 2024 to 2030. The growth in the genome editing market is driven by rising demand for synthetic genes, the application of CRISPR technology, and government funding... Read More »
April 2024The U.S. 3D cell culture market size was valued at USD 564.2 million in 2023 and is expected to grow at a CAGR of 11.0% from 2024 to 2030. The growth of the market is attributable to increasing availability of funding programs for research and development of potential alternatives for an... Read More »
April 2024The U.S. biotechnology instruments market was valued at USD 34.66 billion in 2023 and is expected to grow at a CAGR of 3.45% from 2024 to 2030 which can be attributed to the high demand and affordability of biotechnology instrumentation. Moreover, inclination toward manual automation in ... Read More »
April 2024The U.S. circulating tumor cells market size was estimated at USD 4.45 billion in 2023 and is expected to grow at a CAGR of 12.77% from 2024 to 2030. Some key drivers are increased awareness of cancer treatment and improved healthcare facilities. Technological developments, in ... Read More »
April 2024The U.S. genotyping market size was estimated at USD 6.42 billion in 2023 and is expected to grow at a CAGR of 13.7% from 2024 to 2030. Rising prevalence of genetic disorders & cancer, technological advancements, increased focus on developing personalized medicine, and increasing R&a... Read More »
April 2024The U.S. exosomes market size was estimated at USD 73.58 million in 2023 and is expected to grow at a CAGR of 34.20% from 2024 to 2030. Exosome applications are advancing, which is driving market growth. Technological advancements in exosome isolation and analytical procedures are contri... Read More »
April 2024The U.S. antisense and RNAi therapeutics market size was estimated at USD 2.76 billion in 2023 and is expected to grow at a CAGR of 19.10% from 2024 to 2030. Multidisciplinary applications of antisense technology in various diseases, growing cancer prevalence, and favorable government in... Read More »
April 2024The Middle East stem cell market size was estimated at USD 694.0 million in 2023 and is projected to witness a CAGR of 7.56% from 2024 to 2030. The market’s growth can be attributed to the rising prevalence of chronic diseases such as cardiovascular diseases, and cancer. Growing aw... Read More »
March 2024The U.S. aptamers market size was valued at USD 950.3 million in 2023 and is expected to grow at a CAGR of 24.3% from 2024 to 2030. Recent innovations in purification, generation, and drug delivery for eliminating target cells have driven the attention of many researchers toward aptamers... Read More »
March 2024The U.S. protein labeling market size was estimated at USD 932.2 million in 2023 and is expected to grow at a CAGR of 8.09% from 2024 to 2030. The key growth factors include the development of high-throughput proteomics platforms, advancements in mass spectrometry, and the integration of... Read More »
March 2024The U.S. cell banking outsourcing market size was estimated at USD 5.16 billion in 2023 and is expected to grow at a CAGR of 14.79% from 2024 to 2030. The driving factors for this growth include the rising cryopreservation & cell bank preparation methodologies, and escalating demand ... Read More »
March 2024The U.S. downstream processing market size was estimated at USD 11.35 billion in 2023 and is expected to grow at a CAGR of 14.3% from 2024 to 2030. Major players are focused on streamlining the downstream process and reducing the overall cost of the procedure and the product. Downstream ... Read More »
March 2024The U.S. Cell and gene therapy manufacturing market was valued at USD 3.89 billion in 2023. It is anticipated to experience a CAGR of 27.1% from 2024 to 2030. Advanced therapies have significantly impacted the treatment of numerous rare and life-threatening diseases and revolutionized th... Read More »
March 2024The U.S. gene synthesis market size was estimated at USD 691.1 million in 2023 and is expected to grow at a CAGR of 16.0% from 2024 to 2030. The market growth is significantly influenced by the presence of several key market participants offering gene synthesis services and increasing in... Read More »
March 2024The U.S. life science tools market size was estimated at USD 56.61 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.3% from 2024 to 2030. This can be attributed to a rise in government funding for life science technologies, growth of cell & gene therapies, increase in demand f... Read More »
March 2024The U.S. stem cells market size was estimated at USD 4.79 billion in 2023 and is expected to grow at a CAGR of 9.5% from 2024 to 2030. Increase in acceptance of regenerative medicine and rise in number of regulatory approvals of stem cell therapies are expected to drive the market. Growi... Read More »
March 2024The U.S. CRISPR and Cas genes market size was valued at USD 1.07 billion in 2023 and is anticipated to grow at a CAGR of 16.5% from 2024 to 2030. Therapeutic applications of CRISPR and Cas genes, rising significance for gene editing, and the introduction of anti-CRISPR proteins are boost... Read More »
March 2024The U.S. gene therapy market size was estimated at USD 3.11 billion in 2023 and is expected to grow at a CAGR of 19.21% from 2024 to 2030. The gene therapy market includes DNA-based therapies involving the delivery of a functional copy of a defective gene or the correction of a mutated g... Read More »
March 2024